THQ Tekla Healthcare Opportunities

USD 19.17 0.09 0.471698
Icon

Tekla Healthcare Opportunities (THQ) Stock Analysis and Price Targets

FUND | Asset Management | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 19.17

+0.09 (+0.47)%

USD 0.64B

0.10M

N/A

N/A

Icon

THQ

Tekla Healthcare Opportunities (USD)
FUND | NYE
USD 19.17
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.64B

N/A

USD 19.17

Tekla Healthcare Opportunities (THQ) Stock Forecast

N/A

Based on the Tekla Healthcare Opportunities stock forecast from 0 analysts, the average analyst target price for Tekla Healthcare Opportunities is not available over the next 12 months. Tekla Healthcare Opportunities’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Tekla Healthcare Opportunities is Bullish , which is based on 3 positive signals and 1 negative signals. At the last closing, Tekla Healthcare Opportunities’s stock price was USD 19.17. Tekla Healthcare Opportunities’s stock price has changed by +1.48% over the past week, -2.74% over the past month and -0.21% over the last year.

No recent analyst target price found for Tekla Healthcare Opportunities
No recent average analyst rating found for Tekla Healthcare Opportunities

Company Overview Tekla Healthcare Opportunities

100 Federal Street, Boston, MA, United States, 02110

0

December

USD

USA

Adjusted Closing Price for Tekla Healthcare Opportunities (THQ)

Loading...

Unadjusted Closing Price for Tekla Healthcare Opportunities (THQ)

Loading...

Share Trading Volume for Tekla Healthcare Opportunities Shares

Loading...

Compare Performance of Tekla Healthcare Opportunities Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for THQ

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Tekla Healthcare Opportunities (Sector: Asset Management )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BX
Blackstone Group Inc -1.92 (-1.60%) USD154.61B 68.96 N/A

ETFs Containing THQ

Symbol Name THQ's Weight Expense Ratio Price(Change) Market Cap
CCEF
Calamos CEF Income & Arbi.. 3.94 % 2.74 % +0.07 (+0.28%) USD4.49M

Frequently Asked Questions About Tekla Healthcare Opportunities (THQ) Stock

Stock Target Advisor's fundamental analysis for Tekla Healthcare Opportunities's stock is Bullish .

THQ stock's dividend yield is 9.27%. Our analysis grades THQ stock's dividend yield at D+. This means that THQ stock's dividend yield is above 67% of the stocks in the Asset Management sector in the NYE exchange. Based on this THQ may be a average dividend stock for its sector.

Unfortunately we do not have enough data on THQ's stock to indicate what its average analyst target is.

THQ stock's Price/Earning ratio is 6.90. Our analysis grades THQ stock's Price / Earning ratio at B-. This means that THQ stock's Price/Earning ratio is above 18.99999999999999% of the stocks in the Asset Management sector in the NYE exchange. Based on this THQ may be undervalued for its sector.

The last closing price of THQ's stock was USD 19.17.

The most recent market capitalization for THQ is USD 0.64B.

Unfortunately we do not have enough analyst data on THQ's stock to indicate whether its price will go up or not.

Following are ETFs with the highest allocation to Tekla Healthcare Opportunities's stock :

CCEF

As per our most recent records Tekla Healthcare Opportunities has 0 Employees.

Tekla Healthcare Opportunities's registered address is 100 Federal Street, Boston, MA, United States, 02110. You can get more information about it from Tekla Healthcare Opportunities's website at http://www.teklacap.com/thq.html.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...